TG Therapeutics | Stock

Aktienkurs
28.86
Täglich Wechseln
1.10 3.96%
Monatlich
-4.88%
Jährlich
-12.78%
Q1 Prognose
28.52




Stock Veränderung Datum
AbbVie USD 4.94B 22M 2025-09
Amgen USD 6.22B 121M 2025-12
Ardelyx USD 129.36M 107.08M 2025-09
Arrowhead Research USD -173.08M 173.08M 2024-12
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
Corcept Therapeutics USD 12.35M 73K 2025-09
Dynavax Technologies USD 73.29M 2.4M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
J&J USD 14.15B 734M 2025-09
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 52.69M 18.63M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
TG Therapeutics USD 146.95M 8.25M 2025-09
Vertex Pharmaceuticals USD 1.63B 127.5M 2025-09


TG Therapeutics Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.